Видео ютуба по тегу Aurobindo Pharma Earnings

Aurobindo Pharma Earnings Call for Q4FY21
Aurobindo Pharma Earnings Call for Q4FY21
Aurobindo Pharma’s Growth Engines: CFO S. Subramanian On FY26 Strategy
Aurobindo Pharma’s Growth Engines: CFO S. Subramanian On FY26 Strategy
Aurobindo Pharma Earnings Call for Q4FY20 and Full Year
Aurobindo Pharma Earnings Call for Q4FY20 and Full Year
Aurobindo Pharma Limited (AUROPHARMA) Q4 2025 Earnings – Full Coverage
Aurobindo Pharma Limited (AUROPHARMA) Q4 2025 Earnings – Full Coverage
Aurobindo Pharma Shares Shed 4.5% Post Q1 Earnings | Trading Hour
Aurobindo Pharma Shares Shed 4.5% Post Q1 Earnings | Trading Hour
Aurobindo Pharma Q1FY26 Earnings Concall
Aurobindo Pharma Q1FY26 Earnings Concall
Aurobindo Pharma To Buy Lannet For $250 M, Acquisition To Add $300 M To Aurobindo's Topline
Aurobindo Pharma To Buy Lannet For $250 M, Acquisition To Add $300 M To Aurobindo's Topline
Aurobindo Pharma Earnings call Q3 FY 24 | 10-FEB-24
Aurobindo Pharma Earnings call Q3 FY 24 | 10-FEB-24
Aurobindo Pharma Q1. Total Income Rises 12.9%
Aurobindo Pharma Q1. Total Income Rises 12.9%
Aurobindo Pharma Financial Model | Income Statement forecasting |Part -1 #investing #finance
Aurobindo Pharma Financial Model | Income Statement forecasting |Part -1 #investing #finance
Aurobindo Pharma Earnings Call for Q1FY22
Aurobindo Pharma Earnings Call for Q1FY22
'Big Bull' Rakesh Jhunjhunwala Questions Aurobindo Pharma's Management
'Big Bull' Rakesh Jhunjhunwala Questions Aurobindo Pharma's Management
Aurobindo Pharma Earnings Call for Q1FY21
Aurobindo Pharma Earnings Call for Q1FY21
Aurobindo Pharma Slips In Trade After CNBC-TV18 Accesses US FDA Observations For Unit 12
Aurobindo Pharma Slips In Trade After CNBC-TV18 Accesses US FDA Observations For Unit 12
Aurobindo Pharma Earnings Call for Q2FY21
Aurobindo Pharma Earnings Call for Q2FY21
Aurobindo Pharma Earnings Call for Q3FY21
Aurobindo Pharma Earnings Call for Q3FY21
N Govindarajan of Aurobindo Pharma speaks on Q2 performance | Earnings with ET Now
N Govindarajan of Aurobindo Pharma speaks on Q2 performance | Earnings with ET Now
Aurobindo Pharma Earnings Call for Q4FY22
Aurobindo Pharma Earnings Call for Q4FY22
Aurobindo Pharma Q1 Results Preview: Growth Ahead or Flat Earnings?
Aurobindo Pharma Q1 Results Preview: Growth Ahead or Flat Earnings?
Aurobindo Pharma Earnings Call for Q2FY22
Aurobindo Pharma Earnings Call for Q2FY22
Aurobindo Pharma Income Statement Analysis | Sales 4X | But Stock Down -31%
Aurobindo Pharma Income Statement Analysis | Sales 4X | But Stock Down -31%